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CLINICAL PREDICTORS OF ABNORMAL
ESOPHAGEAL pH MONITORING IN
PRETERM INFANTS
Maria Aparecida MEZZACAPPA and Ana Cecília ROSA
ABSTRACT - Background - Risk factors for gastroesophageal reflux disease in preterm neonates have not been yet clearly defined. Aim - To 
identify factors associated with increased esophageal acid exposition in preterm infants during the stay in the neonatal unit. Methods - A case-
control study in preterm infants who had undergone prolonged monitoring of distal esophageal pH, following clinical indication. Eighty-seven 
preterms with reflux index (percentage of total time of esophageal pHmetry) ≥10% (cases) and 87 unpaired preterms were selected with reflux 
index <10% (controls). Demographic variables, signs and symptoms, main diagnoses and some aspects of treatment were studied. Simple 
and multiple logistic regression analysis adjusted for birthweight and postconceptional age at the pH study were used. Results - The factors 
associated with a greater chance of reflux index ≥10% in preterms were: vomiting, regurgitation, Apnea, female gender. The variables that 
were associated with a lower frequency of increased reflux index were: volume of enteral intake at the onset of symptoms ≥147 mL/kg/day, 
and postnatal corticoid use. Conclusions - Vomiting, regurgitation, apnea, female gender and acute respiratory distress during the first week 
of life were variables predictive of increased esophageal acid exposition in preterm infants with birthweight <2000 g. Bronchopulmonary 
dysplasia and use of caffeine were not associated with reflux index ≥10%.
HEADINGS - Gastroesophageal reflux. Gastric acidity determination. Risk factors. Infant, premature. 
INTRODUCTION
In the past 10 years, a substantial increase has occurred in 
the number of studies on gastroesophageal reflux (GER) in 
preterm infants(11, 17, 26, 29). However, many aspects concerning 
GER in the neonatal period remain controversial or have 
still to be clearly defined(21, 29, 31). Despite the uncertainties, 
neonatal units worldwide continue to treat around 19% of 
preterm infants of less than 34 weeks of gestational age 
(GA) with empiric antireflux therapy(8, 36).
Retrograde flow of gastric contents to the esophagus 
is very common in healthy preterm(19), and may be 
characterized by vomiting or regurgitation without any other 
type of manifestation. The term gastroesophageal reflux 
disease (GERD) may be applied in complicated GER, if 
associated with low weight gain, anemia and irritability, 
or respiratory signs, such as apnea or laryngitis(35).
The wide use of antireflux therapy in newborn infants 
with clinical manifestation attributed to GERD has been 
discouraged(21, 31). However, there is a physiological 
rationale that explains the relationship between GER and 
symptoms such as apnea(33), and evidence that clinical or 
surgical treatment may result in improvement or complete 
remission of symptoms(2, 13, 25).
Definitive diagnosis of GERD in preterms is difficult. In 
addition to the non-specificity of the signs and symptoms, 
laboratory investigation is hampered by a lack of gold 
standard tests for diagnosis in this age group(28). Moreover, 
the previous reports, which are not conclusive about the 
relationship between symptoms and GER, they present 
some pitfalls because they have studied heterogeneous 
groups of infants with few digestive symptoms(29), 
inaccurate definition of GERD or short period with acid in 
esophagus(18). The identification of the factors associated 
with abnormal esophageal pH monitoring in preterm 
infants with symptoms/signs attributed to GERD may 
help proper diagnoses and treatment of such disease.
The objective of this study was to identify the factors 
associated with increased acid esophageal exposition in 
preterm infants by using intra-esophageal pH assessment 
during hospitalization in a neonatal unit.
METHODS
An observational retrospective, case-control study 
was carried out. The study sample was selected from 
among all patients who had undergone prolonged distal 
intra-esophageal pH monitoring, following clinical 
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indication by the medical team, between October 1995 and May 
2002. Selection criteria comprised the following: birthweight 
<2000 grams and gestational age ≤37 weeks, as established 
by the date of last menstrual period or by using the method 
described by BALLARD et al.(3). The cases included preterm 
infants with symptoms suggestive of GERD and reflux index 
(RI – percentage of the time that the esophagus is exposed 
to a pH of less than 4 during de recording period) ≥10%(34). 
Likewise, the controls consisted of patients investigated for 
clinically suspected GERD and hospitalized during the same 
period of time as the cases; however, RI values of controls 
were <10%. The groups were unpaired and only one control 
was chosen for each case. Preterm infants were excluded 
from the study when their monitoring was performed under 
non-standardized conditions or when technical problems 
were encountered.
Esophageal pH was monitored using 1.5 mm catheters with an 
antimonium electrode (Synectics Medical, TX, USA) positioned 
in the distal third of the esophagus at the T6-T7 level. The position 
of the electrode was confirmed by chest x-ray. The Digitrapper 
MkIII (Synectics Medical, TX, USA) was used to record the 
data analyzed using the EsopHogram software program, version 
5.60C4 (Gastrosoft Inc., TX, USA). The duration of monitoring 
ranged from 18 to 24 hours, and the infants remained in supine 
or prone position for equal time during the testing. The enteral 
intake was 130-140 mL/kg/day and feeding was given by bolus 
administration every 3 or 4 hours through a gastric tube. Caffeine, 
prokinetics and antacids were discontinued 48-72 hours prior 
to pH monitoring.
Clinical signs and symptoms, demographical characteristics, 
main clinical diagnoses and some therapeutic aspects of the infants 
were selected as independent variables. Signs and symptoms 
included >3 episodes/day of regurgitation or vomiting, always 
associated with other symptoms suggestive of GERD. Episodes 
of late onset apnea unresponsive to caffeine were considered as 
manifestations related to GERD(25). Apneas that persisted beyond 
36 weeks of postconceptional age(9) and acute life-threatening 
events requiring resuscitation or intermittent mandatory ventilation 
(IMV) comprised other indications. Isolated desaturations (<87%) 
or bradycardia (heart rate <80 bpm), back-arching and laryngeal 
stridor comprised other signs studied.
Other possible risk factors considered were: adequacy of 
weight for gestational age(4), acute respiratory distress (ARD) 
during the 1st week of life, bronchopulmonary dysplasia (BPD)
(32), malformations of the central nervous system, perinatal 
asphyxia, periventricular leukomalacia and peri-intraventricular 
hemorrhage, grades III and IV. The procedures studied were the 
duration of use of gastric tube prior to pH monitoring, the volume 
of feedings at the onset of clinical manifestations, the use and 
duration of IMV and the continuous positive airway pressure 
(CPAP) in the 1st week of life.
Feeding intolerance was defined as dietary difficulties 
(abdominal distension, bilious or lactic residues of more than 50% 
of the previous feeding volume) that resulted in discontinuation 
of at least one feeding in the 1st days of the transition to enteral 
route. Pre- and postnatal corticoid, pulmonary surfactant, 
caffeine, opioids, dopamine and systemic bronchodilators were 
the drugs studied.
The SAS statistical software program, version 6.12 for 
Windows (SAS Institute Inc., NC, USA) was used for the 
statistical analysis. The chi-squared test was used to analyze 
the categorical variables between the two groups and the Mann-
Whitney U test for the comparison of the numerical variables. 
Simple and multiple logistic regression analysis(14), adjusted for 
the variables of birthweight and postconceptional age (PCA) at 
the time of pH study, were used to establish the odds ratio (OR) 
and the 95% confidence intervals. The stepwise selection criteria 
was applied to the variables, taking into consideration those 
variables with P<0.25 in the univariate analysis. Significance 
was established as P<0.05. The institute’s Internal Review Board 
approved the study protocol.
RESULTS
During the study period, 235 esophageal pH monitoring studies 
were carried out in 193 preterm infants. Studies of pH were 
routinely carried out whenever neonatal GERD was suspected 
except in patients in whom vomiting and regurgitation were the only 
symptom and in preterms with severe neurological impairments. 
Eighty-seven cases (RI ≥10%) and 87 controls (RI <10%) fulfilled 
inclusion criteria. The distribution of demographic data and the 
symptoms in the two groups are shown in Table 1.
There were no statistically significant differences between 
cases and controls with respect to the distribution of the symptoms 
except for vomiting and regurgitation, which were more common 
among cases (Table 1).
The moment of onset of symptoms was similar in both 
groups: 11.0 ± 7.9 days of life for cases and 12.8 ± 8.7 
days for controls (P = 0.165). Evaluation of pH was carried 
out at an earlier PCA in cases than in controls (Table 1). 
Cases had a mean RI of 21.6% ± 9.6% (median = 18.9%; 
range = 10.3%-66.4%; 25P-75P = 14.5%-27.8%), whereas 
controls had a mean RI of 4.6% ± 2.9% (median = 4.5%, 
range = 0%-9.0%; 25P-75P = 2.5%-6.8%). Digestive malformations 
(n = 2), malformations of the central nervous system (n = 2), 
and necrotizing enterocolitis (n = 8) were infrequent and were 
not associated with any specific group. There were no cases 
of genetic syndromes.
The duration of use of gastric tube was more frequent in the 
control group: 47.7 ± 19.3 days (median 45, range 3-114) versus 
42.5 ± 16.7 days (median 39, range 18-92) but this difference was 
not statistically significant (P = 0.063). In 119 newborn infants 
(68%), there was an association between symptoms and the 
volume of enteral intake, 58 of these infants being cases and 61 
controls. The volume of the feeding immediately preceding the 
onset of symptoms was significantly lower in the cases compared 
to the controls: 73.5 ± 54.8 mL/kg/day (median 64.0) versus 
95.7 ± 58.4 mL/kg/day (median 100.0) (P = 0.036).
Univariate logistic regression, adjusted for the variables 
birthweight and PCA, showed that RI ≥10% was significantly 
more frequent in female infants and in infants with vomiting 
and regurgitation (Table 2). Postnatal use of corticoids and a 
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TABLE 1. Distribution of the demographic variables and symptoms in 
cases (RI≥10%) and controls (RI<10%)
Values presented as mean ± SD;     * Mann-Whitney U-test;     † Chi-square test
g = gram; wk = week; d = day; n = cases; SGA = small for gestational age;
ARD= acute respiratory distress in the first week of life; IMV = intermittent mandatory ventilation; 
CPAP = continuous positive airway pressure; PCA = postconceptional age at the pH study; PVH = 
periventricular and ventricular hemorrhage grade III, IV
Variable Cases 
(n = 87)
Controls 
(n = 87)
P-value
Birth weight (g)
median (range)
1185 ± 290
1180 (650-1990)
1050 ± 310
985 (510-1950)
0.001∗
Gestational age (wk)
median (range)
28.9 ± 2.2
29.0 (24-35)
29.0 ± 2.5
29.0 (23-35)
0.839∗
5-minute Apgar 8.0 ± 1.9 8.0 ± 2.0 0.789∗
Female (n) 44 32 0.067†
SGA (n) 34 44 0.127†
Regurgitation (n) 26 8 <0.001†
Vomiting (n) 43 20 <0.001†
PCA at time of pH study (wk)
median (range)
35.0 ± 2.5
34.7 (29-43)
35.8 ± 2.9
35.4 (30-42)
0.045∗
Apnea (n) 82 76 0.115†
ARD (n) 72 65 0.195†
Bronchopulmonary dysplasia (n) 33 44 0.093†
PVH (n) 7 9 0.600†
Perinatal asphyxia (n) 8 6 0.577†
Periventricular leukomalacia (n) 6 6 1.000†
Feeding intolerance (n) 62 52 0.111†
IMV (n) 63 74 0.042†
Ventilation (d) 12.1 ± 12.4 17.7 ± 16.5 0.110∗
CPAP (n) 61 70 0.114†
Surfactant (n) 23 17 0.280†
Caffeine (n) 70 71 0.847†
Bronchodilator (n) 23 39 0.011†
Dopamine (n) 37 45 0.224†
Opioid (n) 27 22 0.399†
Prenatal steroid (n) 49 43 0.362†
Postnatal steroid (n) 7 25 <0.001†
TABLE 2. Univariate logistic regression analysis (n = 174), adjusted for 
the birthweight and postconceptional age at time of pH study
OR = odds-ratio for GERD; CI = confidence interval; GA = gestational age;
SGA = small for gestational age; ARD = acute respiratory distress in the first week of life; PVH = periventricular 
and ventricular hemorrhage grade III, IV;
IMV = intermittent mandatory ventilation; CPAP = continuous positive airway pressure
* P75 value of sample
Variable P-value OR 95% CI
For each week less of GA 0.125 0.84 0.68-1.05
Female 0.040 1.94 1.03-3.65
SGA 0.767 0.91 0.47-1.75
Regurgitation 0.001 4.58 1.85-11.33
Vomiting <0.001 3.25 1.65-6.40
Bronchopulmonary dysplasia 0.742 0.89 0.46-1.75
Apnea 0.103 2.57 0.83-8.01
ARD 0.006 2.12 0.97-4.63
PVH 0.728 0.83 0.29-2.39
Perinatal asphyxia 0.499 1.49 0.47-4.68
Periventricular leukomalacia 0.725 0.80 0.24-2.72
Feeding intolerance 0.054 1.93 0.99-3.76
IMV 0.228 0.61 0.28-1.36
CPAP 0.547 0.79 0.37-1.69
For each day of use of gastric tube 0.124 1.03 0.99-1.06
Enteral intake pre-symptoms ≥147 mL/kg/day* 0.044 0.36 0.14-0.98
Surfactant 0.209 1.61 0.77-3.38
Caffeine 0.440 1.42 0.58-3.47
Opioid 0.241 1.52 0.75-3.08
Dopamine 0.622 0.85 0.46-1.60
Prenatal steroid 0.565 1.20 0.65-2.23
Postnatal steroid 0.018 0.32 0.12-0.82
Bronchodilator 0.186 0.62 0.31-1.25
pre-symptom enteral volume ≥147 mL/kg/day were identified 
as protective factors (Table 2).
The variables used in the multivariate logistic regression were 
those with a P-value <0.25 in the univariate analysis (Table 2). 
We obtained distinct results in two models. When symptoms 
were carried on in multivariate analysis the set of variables 
that better defined the risk of IR ≥10% were the following: 
vomiting OR = 3.29 (IC95% 1.62-6.71), P = 0.001; regurgitations 
OR = 4.94 (IC95% 1.89-12.96), P = 0.001 and apnea OR = 4.28 
(IC95% 1.19-15.43), P = 0.026. When symptoms were excluded 
of the multivariate analysis ARD was identified as a risk factor 
and postnatal use of steroid remained in the model as protective 
variable for RI ≥10% (Table 3).
The duration of hospitalization and weight at discharge from 
hospital were similar in the two groups: 69.1 ± 26.2 days and 2413 
± 457 grams, respectively, in the cases versus 74.7 ± 28.4 days 
(P = 0.099) and 2332 ± 414 g (P = 0.422) in the controls.
DISCUSSION
This paper evaluated a large number of preterm infants 
with clinical manifestations suggestive of GERD with high 
RI values (mean 21.6%% ± 9.6%) and identified symptoms, 
demographic variables and factors related to intensive care that 
were associated with RI ≥10% either independent or as part of 
a set of variables. 
Diagnosis of GERD in premature infants is hampered by 
various aspects, specially the lack of well-defined clinical and 
laboratory parameters. Esophageal pH monitoring is far from 
routine in neonatal units(8, 36) and a definition of normal values 
of RI remains to be established. Therefore, the threshold value 
for the RI varies from one author to another (>5%–15%)(1, 7). In 
this study, an RI ≥10% was adopted as in other studies(12) and 
corresponds to the 90th percentile in term infants(34). The mean 
of RI achieved here were similar to other recent papers(26, 27).
TABLE 3. Multivariate logistic regression analysis (n = 174), excluding 
the symptoms suggestive of DRGE, adjusted for the birthweight and 
postconceptional age at time of pH study
ARD = acute respiratory disease in the first week of life
Variable P-value OR 95% CI
ARD 0.022 2.51 1.14-5.51
Postnatal steroid 0.008 0.26 0.10-0.70
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DRGE has presented low incidence in preterms(1, 11) so the use 
of case-control study is more efficient than prospective studies. 
The selection of a control group is a critical issue in case control 
studies. Unhealthy preterms with clinic manifestations suggestive 
of GERD were selected. The use of infants without reflux-like 
symptoms may establish a systematic difference related to 
exposure between the groups and distort the odds-ratio. So, the 
two groups were similar in respect to the majority of the variables 
studied. However, mean birthweight was significantly lower in 
the controls and the PCA at pH study was younger in the cases. 
Therefore, to eliminate a possible confounding effect, regression 
analysis was adjusted according to the two variables. 
The authors who have suggested a causal relationship between 
GER and apnea in preterm infants have emphasized the importance 
of associated digestive manifestations in these patients(13, 20, 21). 
In fact, this study found that digestive manifestations were more 
common (3-5 times) in cases (IR ≥10%) than in the controls 
(IR <10%). Those results were confirmed by multivariate analysis 
where apnea, vomiting and regurgitations all together define the 
risk for IR ≥10%. This result does not allow us to accept or reject 
the hypothesis of causality between GER and apnea. Although 
there is a physiological substrate that explains the relationship 
between GER and apnea(33) it is believed that in the majority 
of cases, apnea and GER merely coexist in premature infants 
as manifestations of immaturity with no causal relationship 
between them(21, 31).
Female gender was associated with high RI. The authors 
disagree that in adults the association between DRGE and gender 
may occur, but there are descriptions of predominance of DRGE 
in females(22). Emotional status and ingestion of particular foods 
were implicated(22) but hormonal influences may not be disregarded. 
Gender association with greater esophageal acid exposure have 
been reported in caucasian female infants(24). 
Another result that has also not been previously reported is 
postnatal corticoid as a protective factor for increased IR. This 
result may be associated with a greater number of infants with 
BPD among controls. In this study, in the various models of 
multivariate analysis either, adjusted or not for the variable BPD, 
the OR for postnatal corticoid use remained strongly significant. 
Prenatal use of corticoid is known to be related to maturation 
of the intestinal motor pattern in premature infants(23) and has 
been related to an increase in GERD(6). Inversely, no effect of 
postnatal corticoid on gastrointestinal motility has been previously 
described. Therefore, further studies are required to evaluate the 
possible effects of prenatal and postnatal corticoids in GERD.
We investigated the effect of the volume of feedings prior 
to the onset of symptoms, since great volumes are important 
determinants of episodes of reflux(7, 35). In addition, we observed 
that the cases had an onset or deterioration in apnea and 
desaturations as the volume of feedings increased, although this 
association was not specific for GERD(5). Unexpectedly, a volume 
≥147 mL/kg/day pre-symptoms was found to be a protective 
factor for the occurrence of increased RI, meaning that the control 
group tolerated the increase in feeding volume better than the 
study group. The 30 infants who showed symptoms only when 
the volume of enteral intake was ≥147 mL/kg/day, 67% were 
controls and 33% cases. The volume of the feeding immediately 
preceding the onset of symptoms was significantly lower in 
the cases. Nevertheless, the OR for GERD with lower feeding 
volumes (values corresponding to the P25, P25-P75 of sample) 
was not significant.
The exclusion of symptoms of the multiple analysis makes 
feasible the expression of another two variables that define the 
chance of RI ≥10%. Together with postnatal corticoid, the respiratory 
insufficiency was identified as a factor that increases the chance 
(OR = 2.51) of IR ≥10%. This result agrees with the previous 
anecdotal reports that respiratory distress syndrome during the 
first week of life is associated with a diagnosis of GERD(13, 16, 
17). In addition, there is recent evidence that preterm infants with 
respiratory distress syndrome on mechanical ventilation are at 
risk of pulmonary aspiration since the first days of life(10).
The use of a gastric tube triggers almost twice the number 
of reflux episodes in preterm infants(30). In this study neither the 
frequency nor duration of use of the gastric tube was associated 
with greater esophageal acid exposition. Likewise, caffeine, 
traditionally considered to be a risk factor for GERD, was not 
relevant in this study, in agreement with data already published 
by other investigators(2, 7, 26)
BPD has been frequently considered a risk factor for GERD(13, 
16) and its presence in these patients ranges from 18.4%–63.0%(1, 
15). In our study, no association was found between BPD and 
RI ≥10%. These findings agrees with data published by other 
investigators(1, 17) and allow us to speculate that the greater 
frequency of diagnosis of GERD in premature infants with BPD 
may occur as a result of the greater frequency of ARD in these 
patients, in the first week of life.
One limitation of this study is the absence of information 
regarding the racial constitution of the sample. In both children 
and adults, GERD affects predominantly caucasians(24). A 
further limitation is the small sample of patients with serious 
neurological impairments. Such children are known to have a 
high incidence of GERD(16).
GERD in newborn infants has been associated with longer 
hospital stays(11) and higher costs. The duration of hospital stay 
was similar in both groups, probably due to the early diagnosis 
and initiation of conservative treatment (posture and dietary 
management).
In conclusion, this study found that vomiting and regurgitation, 
apnea, female gender, and respiratory failure in the first days 
of life were variables predictive of increased RI and feasible 
GERD in preterm infants with birthweight <2000 g. These 
findings may be helpful in clinical management and may allow 
selection of more appropriate sample populations for future 
clinical research trials.
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